Aytu BioScience's total assets for Q2 2026 were $122.00M, a decrease of -2.39% from the previous quarter. AYTU total liabilities were $107.80M for the fiscal quarter, a 5.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.